ATH 0.00% 0.3¢ alterity therapeutics limited

potential blood test early alzheimers, page-10

  1. 1,619 Posts.
    lightbulb Created with Sketch. 80
    This is what puts the cherry on Prana's Cream ... Win win win.. Brokers and analysts are playing with our brains with SP... but the future is rivers of Gold... we can't go wrong from here.... things are falling in place for the long run... I've topped up today... and will do at every opportunity...

    "A successful test for Alzheimer's could transform medical research and treatment drugs could be tested at a much earlier stage in the disease.

    Prof Federoff said slowing the pace of the disease could have a huge impact: "Even a short delay of symptoms will have a tremendous economic benefit just in terms of the cost of care."

    Dr Simon Ridley, from the charity Alzheimer's Research UK, said the findings were "encouraging" and that a blood test would be a "real step forward".
    he added: "To test the effectiveness of potential new drugs, it's important to be able to recruit people to clinical trials in the early stages of the disease, when such treatments are most likely to be effective.

    "If confirmed, these results could also aid efforts to develop better tools for diagnosing Alzheimer's - allowing people with the disease to access crucial support and existing treatments sooner."
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.937K 645.7K

Buyers (Bids)

No. Vol. Price($)
77 96988980 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 655773 2
View Market Depth
Last trade - 10.00am 15/11/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.